Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · IEX Real-Time Price · USD
29.04
+0.53 (1.86%)
Mar 27, 2024, 4:00 PM EDT - Market closed

Pacira BioSciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2008
Cash & Equivalents
153.3104.14585.5899.9678.23132.5354.1335.9456.9839.03
Upgrade
Short-Term Investments
125.28184.5170.83421.71213.72250.93257.22136.65101.98119.14
Upgrade
Cash & Cash Equivalents
278.58288.65656.41521.66291.95383.45311.35172.6158.97158.17
Upgrade
Cash Growth
-3.49%-56.03%25.83%78.68%-23.86%23.16%80.39%8.58%0.50%114.36%
Upgrade
Receivables
105.5698.496.3253.0547.533831.6629.9425.8622.37
Upgrade
Inventory
104.3596.0698.5564.6558.348.5741.4131.2861.6529.26
Upgrade
Other Current Assets
21.515.2214.7712.2710.787.956.699.286.124.46
Upgrade
Total Current Assets
509.99498.33866.05651.62408.56477.97391.11243.09252.58214.26
Upgrade
Property, Plant & Equipment
234.95254.39264.81211.18142.81108.67107.05101.0290.3260.63
Upgrade
Long-Term Investments
38.4664.3821.99109.4875.7740.6774.19013.4624.43
Upgrade
Goodwill and Intangibles
646.5703.79769.14196.07203.9362.0455.246.7430.9624.16
Upgrade
Other Long-Term Assets
144.49160.31153.36106.16000.830.620.412.59
Upgrade
Total Long-Term Assets
1,0641,1831,209622.89422.51211.38237.26148.38135.15111.82
Upgrade
Total Assets
1,5741,6812,0751,275831.07689.35628.37391.47387.74326.07
Upgrade
Accounts Payable
15.715.2210.5410.4312.814.3714.667.518.746.76
Upgrade
Deferred Revenue
0000000.10.69.5110.93
Upgrade
Current Debt
17.4442.77382.59157.074.940.340.320104.04103.1
Upgrade
Other Current Liabilities
64.2489.79127.9885.8289.9445.9641.1336.7327.519.22
Upgrade
Total Current Liabilities
97.38147.77521.12253.33107.6760.6656.2244.84149.79140.01
Upgrade
Long-Term Debt
568.6720.63746.26384.06346.98290.59276.17108.7400
Upgrade
Other Long-Term Liabilities
38.2737.7977.5717.4421.4716.8716.518.9119.5614.92
Upgrade
Total Long-Term Liabilities
606.87758.42823.83401.5368.45307.47292.67127.6519.5614.92
Upgrade
Total Liabilities
704.26906.191,345654.83476.12368.13348.89172.49169.34154.93
Upgrade
Total Debt
586.04763.391,129541.13351.92290.93276.5108.74104.04103.1
Upgrade
Debt Growth
-23.23%-32.37%108.61%53.77%20.96%5.22%154.28%4.52%0.91%4.18%
Upgrade
Retained Earnings
-106.8-148.75-211.9-253.88-399.4-388.23-389.14-346.24-308.29-310.15
Upgrade
Comprehensive Income
0.25-0.380.170.320.32-0.28-0.45-0.03-0.05-0.08
Upgrade
Shareholders' Equity
870.13775.01730.41619.69354.94321.23279.48218.98218.39171.15
Upgrade
Net Cash / Debt
-307.46-474.74-472.44-19.47-59.9792.5234.8563.8654.9355.07
Upgrade
Net Cash / Debt Growth
-----165.49%-45.43%16.27%-0.26%-
Upgrade
Net Cash Per Share
-5.92-10.20-10.35-0.45-1.442.260.881.711.331.56
Upgrade
Working Capital
412.61350.56344.93398.3300.88417.31334.89198.25102.7974.25
Upgrade
Book Value Per Share
18.8217.0216.5014.528.557.857.025.885.984.85
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).